A citation-based method for searching scientific literature

Anissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, Roberto Gil, Diana Martinez, Yiyun Huang, Dah-Ren Hwang, John Keilp, Lisa Kochan, Ronald Van Heertum, Jack M Gorman, Marc Laruelle. J Neurosci 2002
Times Cited: 500







List of co-cited articles
1131 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Y Okubo, T Suhara, K Suzuki, K Kobayashi, O Inoue, O Terasaki, Y Someya, T Sassa, Y Sudo, E Matsushima,[...]. Nature 1997
517
36


Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.
Susheel Vijayraghavan, Min Wang, Shari G Birnbaum, Graham V Williams, Amy F T Arnsten. Nat Neurosci 2007
642
25

Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.
Anissa Abi-Dargham, Xiaoyan Xu, Judy L Thompson, Roberto Gil, Lawrence S Kegeles, Nina Urban, Raj Narendran, Dah-Ren Hwang, Marc Laruelle, Mark Slifstein. J Psychopharmacol 2012
90
26


Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
Mark Slifstein, Elsmarieke van de Giessen, Jared Van Snellenberg, Judy L Thompson, Rajesh Narendran, Roberto Gil, Elizabeth Hackett, Ragy Girgis, Najate Ojeil, Holly Moore,[...]. JAMA Psychiatry 2015
185
19



The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Oliver D Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur. Arch Gen Psychiatry 2012
530
17

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.
Patricia S Goldman-Rakic, Stacy A Castner, Torgny H Svensson, Larry J Siever, Graham V Williams. Psychopharmacology (Berl) 2004
374
16




Dopamine in schizophrenia: a review and reconceptualization.
K L Davis, R S Kahn, G Ko, M Davidson. Am J Psychiatry 1991
14

The physiology, signaling, and pharmacology of dopamine receptors.
Jean-Martin Beaulieu, Raul R Gainetdinov. Pharmacol Rev 2011
13

PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
Per Karlsson, Lars Farde, Christer Halldin, Göran Sedvall. Am J Psychiatry 2002
122
12

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
A Abi-Dargham, J Rodenhiser, D Printz, Y Zea-Ponce, R Gil, L S Kegeles, R Weiss, T B Cooper, J J Mann, R L Van Heertum,[...]. Proc Natl Acad Sci U S A 2000
673
12

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
Robert B Innis, Vincent J Cunningham, Jacques Delforge, Masahiro Fujita, Albert Gjedde, Roger N Gunn, James Holden, Sylvain Houle, Sung-Cheng Huang, Masanori Ichise,[...]. J Cereb Blood Flow Metab 2007
12

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.
A F Arnsten, J X Cai, B L Murphy, P S Goldman-Rakic. Psychopharmacology (Berl) 1994
398
11

The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
11

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
M Laruelle, A Abi-Dargham, C H van Dyck, R Gil, C D D'Souza, J Erdos, E McCance, W Rosenblatt, C Fingado, S S Zoghbi,[...]. Proc Natl Acad Sci U S A 1996
923
11


Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Isabel Valli, Paul Tabraham, Elvira Bramon-Bosch, Lucia Valmaggia, Louise Johns, Matthew Broome,[...]. Arch Gen Psychiatry 2009
479
10

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Andreas Meyer-Lindenberg, Robert S Miletich, Philip D Kohn, Giuseppe Esposito, Richard E Carson, Mario Quarantelli, Daniel R Weinberger, Karen Faith Berman. Nat Neurosci 2002
453
10


Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, O Kirvelä, U Ruotsalainen. Lancet 1995
245
9

Dopamine receptors: from structure to function.
C Missale, S R Nash, S W Robinson, M Jaber, M G Caron. Physiol Rev 1998
9




Cellular basis of working memory.
P S Goldman-Rakic. Neuron 1995
9

Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder.
Daniel R Rosell, Lauren C Zaluda, Margaret M McClure, M Mercedes Perez-Rodriguez, K Sloan Strike, Deanna M Barch, Philip D Harvey, Ragy R Girgis, Erin A Hazlett, Richard B Mailman,[...]. Neuropsychopharmacology 2015
58
15


Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
Amy F T Arnsten, Ragy R Girgis, David L Gray, Richard B Mailman. Biol Psychiatry 2017
72
12

NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex.
Min Wang, Yang Yang, Ching-Jung Wang, Nao J Gamo, Lu E Jin, James A Mazer, John H Morrison, Xiao-Jing Wang, Amy F T Arnsten. Neuron 2013
259
8

Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
Rajesh Narendran, W Gordon Frankle, N Scott Mason, Eugenii A Rabiner, Roger N Gunn, Graham E Searle, Shivangi Vora, Maralee Litschge, Steve Kendro, Thomas B Cooper,[...]. Synapse 2009
90
8


Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia.
Jun Kosaka, Hidehiko Takahashi, Hiroshi Ito, Akihiro Takano, Yota Fujimura, Ryohei Matsumoto, Shoko Nozaki, Fumihiko Yasuno, Yoshiro Okubo, Toshifumi Kishimoto,[...]. Life Sci 2010
38
21

Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
Lawrence S Kegeles, Anissa Abi-Dargham, W Gordon Frankle, Roberto Gil, Thomas B Cooper, Mark Slifstein, Dah-Ren Hwang, Yiyun Huang, Suzanne N Haber, Marc Laruelle. Arch Gen Psychiatry 2010
343
8

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
A Abi-Dargham, R Gil, J Krystal, R M Baldwin, J P Seibyl, M Bowers, C H van Dyck, D S Charney, R B Innis, M Laruelle. Am J Psychiatry 1998
561
8


Selective D2 receptor actions on the functional circuitry of working memory.
Min Wang, Susheel Vijayraghavan, Patricia S Goldman-Rakic. Science 2004
227
8

D1-dependent 4 Hz oscillations and ramping activity in rodent medial frontal cortex during interval timing.
Krystal L Parker, Kuan-Hua Chen, Johnathan R Kingyon, James F Cavanagh, Nandakumar S Narayanan. J Neurosci 2014
67
11

D(1) receptors in prefrontal cells and circuits.
P S Goldman-Rakic, E C Muly, G V Williams. Brain Res Brain Res Rev 2000
572
8

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
L H Lindström, O Gefvert, G Hagberg, T Lundberg, M Bergström, P Hartvig, B Långström. Biol Psychiatry 1999
196
7




Increased dopamine transmission in schizophrenia: relationship to illness phases.
M Laruelle, A Abi-Dargham, R Gil, L Kegeles, R Innis. Biol Psychiatry 1999
495
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.